Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MgSO4 and Melatonin vs MgSO4 Alone in Hypoxic Ischemic Encephalopathy
NCT07652801Phase 3Not yet recruiting
- Sponsor
- University of Child Health Sciences and Children's Hospital, Lahore
- Start
- Jul 2026
- Primary completion
- Dec 2026
01
Overview
A Phase 3 trial of melatonin in hypoxic-ischemic encephalopathy (HIE), sponsored by University of Child Health Sciences and Children's Hospital, Lahore. Planned start Jul 2026; status: not yet recruiting.
02
Drugs
melatonin
03
Conditions
hypoxic-ischemic encephalopathy (HIE)
Beyond the preview
Go deeper on NCT07652801.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07652801.